Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?
Crossref DOI link: https://doi.org/10.1007/s40744-019-00190-7
Published Online: 2020-01-16
Published Print: 2020-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fleischmann, Roy https://orcid.org/0000-0002-6630-1477
Jairath, Vipul
Mysler, Eduardo
Nicholls, Dave
Declerck, Paul
Funding for this research was provided by:
AbbVie
Text and Data Mining valid from 2020-01-16
Version of Record valid from 2020-01-16
Article History
Received: 10 October 2019
First Online: 16 January 2020